4-氯-1-(3-甲氧基苯基)-1-丁酮 | 258882-48-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-氯-1-(3-甲氧基苯基)-1-丁酮
• 英文名称: 4-chloro-1-(3-methoxyphenyl)-1-butanone
• 英文别名: 4-chloro-1-(3-methoxyphenyl)butan-1-one；5-chloro-1-(3-methoxyphenyl)butan-1-one；4-Chloro-1-(3-methoxyphenyl)-1-oxobutane
• CAS: 258882-48-3
• 化学式: C₁₁H₁₃ClO₂
• 分子量: 212.676
• InChiKey: KQFBLOHOCUJMTC-UHFFFAOYSA-N

物化性质

• 沸点：
  323.0±22.0 °C(Predicted)
• 密度：
  1.123±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914700090

反应信息

• 作为反应物：
  描述：

  4-氯-1-(3-甲氧基苯基)-1-丁酮 在 potassium carbonate 、 三乙胺 、 甲烷磺酰基叠氮化物 、 sodium iodide 作用下， 以 氘代丙酮 、 丙酮 、 乙腈 为溶剂， 反应 18.25h， 生成 methyl 2-diazo-6-(3-methoxyphenyl)-6-oxohexanoate
  参考文献：
  名称：

  酮与α-重氮酯的催化不对称分子内同源性：环状α-芳基/烷基β-酮酸酯的合成

  摘要：

  首先用手性N，N'-二氧化物-Sc（OTf）3配合物完成了简单的酮与α-重氮化合物的催化不对称分子内同源性。这种方法可以有效地获得含有全碳季立体中心的手性环状α-芳基/烷基β-酮酸酯。在温和的条件下，各种芳基和烷基取代的酮基通过分子内加成/重排过程与α-重氮酸酯基团平稳反应，从而以高收率和对映体过量生成β-酮酸酯。

  DOI：

  10.1002/anie.201409572
• 作为产物：
  描述：

  3-甲氧基苯甲醛 在 二异丙胺 、 zinc(II) iodide 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 10.5h， 生成 4-氯-1-(3-甲氧基苯基)-1-丁酮
  参考文献：
  名称：

  A Structure−Affinity Relationship Study on Derivatives of N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a High-Affinity and Selective D₄ Receptor Ligand

  摘要：

  N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (1), a high-affinity and selective dopamine D-4 receptor ligand, was chosen as a lead, and structural modifications were done on its amide bond and on its alkyl chain linking the benzamide moiety to the piperazine ring and by preparing some semirigid analogues. The binding profile at dopamine D-4 and dopamine D-2, serotonin 5-HT1A, and adrenergic ar receptors of 16 new compounds was determined. From the results emerged that the modification of the amide bond and the elongation of the intermediate alkyl chain caused a decrease in dopamine D-4 receptor affinity. All prepared semirigid analogues displayed D-4 receptor affinity values in the same range of the opened counterparts.

  DOI：

  10.1021/jm991138z

文献信息

• A Facile Asymmetric Synthesis of Either Enantiomer of 2-Substituted Pyrrolidines
  作者：Leleti Rajender Reddy、Sonia G. Das、Yugang Liu、Mahavir Prashad

  DOI：10.1021/jo902710s

  日期：2010.4.2

  A new and general method for asymmetric synthesis of either enantiomer of 2-substituted pyrrolidines from a single starting material is described. Reductive cyclization of (SS)-γ-chloro-N-tert-butanesulfinyl ketimines with LiBHEt3 in THF at −78 to 23 °C afforded (SS,R)-N-tert-butanesulfinyl-2-substituted pyrrolidines in excellent yields (88−98%) and with high diastereoselectivity (99:1). The diastereoselectivity

  描述了一种从单一起始原料不对称合成2-取代的吡咯烷的对映异构体的新的通用方法。的（还原性环化小号小号）-γ -氯ñ -叔-butanesulfinyl酮亚胺与LiBHEt 3在THF中，在-78至23℃，得到（小号小号，- [R ）- ñ -叔在优秀-butanesulfinyl -2-取代的吡咯烷收率（88-98％），非对映选择性高（99：1）。通过选择还原剂可以有效地控制非对映选择性。因此，（S S，S只需将还原剂从LiBHEt 3切换到DIBAL-H / LiHMDS，即可以高产率（87-98％）和高非对映选择性（1:99）合成）-2-取代的吡咯烷。的脱保护ñ -叔在二恶烷用4N的HCl -butanesulfinyl -2-取代的吡咯烷和MeOH，得到2-取代的吡咯烷的对映异构体对应于定量收率。发现该方法对于包括芳族，杂芳族和脂族取代基的多种底物是有效的。还说明了该方法扩展到2-取
• SUBSTITUTED BUTYROPHENONE DERIVATIVES
  申请人：Seeman Philip

  公开号：US20100004289A1

  公开（公告）日：2010-01-07

  The present invention relates to a central nervous system-acting substituted butyrophenones. These compounds are useful in antipsychotic medications for psychosis, including schizophrenia, but especially for L-DOPA-induced psychosis, while having low or no risk of eliciting extrapyramidal side effects, hyperprolactinemia or tardive dyskinesia.

  本发明涉及中枢神经系统作用的替代丁酰苯酮。这些化合物在治疗精神病药物中具有用途，包括精神分裂症，但特别适用于L-DOPA诱导的精神病，同时具有低或无诱发锥体外系副作用，高催乳素血症或迟发性运动障碍的风险。
• Chemoselective and Divergent Synthesis of Chlorohydrins and Oxaheterocycles via Ir-Catalyzed Asymmetric Hydrogenation
  作者：Yan Zong、Xiaomei Zou、Jingyuan Song、Gen-Qiang Chen、Xumu Zhang

  DOI：10.1021/acs.orglett.3c02565

  日期：2023.9.22

  Chlorohydrins and oxaheterocycles are synthetically valuable building blocks for diverse natural products and therapeutic substances. A highly efficient Ir/f-phamidol-catalyzed asymmetric hydrogenation of ω-chloroketones was successfully developed, and various chlorohydrins and oxaheterocycles were obtained divergently with excellent yields and enantioselectivities (up to >99% yield and >99% ee). Synthetic

  氯醇和氧杂环是多种天然产物和治疗物质的具有合成价值的结构单元。成功开发了高效的Ir/ f-邻氨基醇催化的ω-氯酮不对称氢化反应，并以优异的产率和对映选择性（高达>99%产率和>99%ee）不同地获得了各种氯代醇和氧杂环。通过这种催化方法对几种对映体富集的药物的关键中间体进行克级合成，证明了这种发散转化的合成效用。
• Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: Highly potent against human enzyme within a cellular environment
  作者：David S. Weinstein、Wen Liu、Khehyong Ngu、Charles Langevine、Donald W. Combs、Shaobin Zhuang、Cindy Chen、Cort S. Madsen、Timothy W. Harper、Jeffrey A. Robl

  DOI：10.1016/j.bmcl.2007.07.011

  日期：2007.9

  A series of 2,4,5-tri-substituted imidazoles has proven to be highly potent in inhibiting mammalian 15-lipoxygenase (15LO) with excellent selectivity over human isozymes 5- and P-12-LO. Non-symmetrical sulfamides (e.g., 21a-n) were found to be suitable replacements for the earlier arylsulfonamide-containing members of this series (e.g., 2, 14a-p). Several members of these series also demonstrated potent inhibition of human 15-LO in a cell-based assay. (c) 2007 Elsevier Ltd. All rights reserved.
• Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase
  作者：Khehyong Ngu、David S. Weinstein、Wen Liu、Charles Langevine、Donald W. Combs、Shaobin Zhuang、Xing Chen、Cort S. Madsen、Timothy W. Harper、Saleem Ahmad、Jeffrey A. Robl

  DOI：10.1016/j.bmcl.2011.05.107

  日期：2011.7

  A series of inhibitors of mammalian 15-lipoxygenase (15-LO) based on a 3,4,5-tri-substituted pyrazole scaffold is described. Replacement of a sulfonamide functionality in the lead series with a sulfamide group resulted in improved physicochemical properties generating analogs with enhanced inhibition in cell-based and whole blood assays. (C) 2011 Elsevier Ltd. All rights reserved.